Research Progress--Shanghai Institut of Immunity and Infection, Chinese Academy of Sciences

27

2011-01

Viral Sequence Evolution in Chinese Genotype 1b Chronic Hepatitis C Patients Experiencing Unsuccessful Interferon Treatment

The team of Prof. Jin Zhong's at Institut Pasteur of Shanghai, Chinese Academy of Sciences，in collaboration with Prof. Qing Xie's team at Shanghai Ruijin Hospital, analyzed HCV genomic sequence evolution in unsuccessfully treated genotype 1b patients before, during and after the interferon based...

18

2011-01

ECM1 controls Th2 cell egress from lymph nodes through re-expression of S1P1

Recently, a research team, led by Prof. SUN Bing, from Shanghai Institute of Biochemistry and Cell Biology (SIBCB), discovered that ECM1 controls Type 2 helper (Th2) cell egress from lymph nodes through re-expression of S1P1.
　　Th2 cells are differentiated from na？ve CD4+ helper T cells, which...

22

2010-06

New international partnership to fight viruses

Institut Pasteur Shanghai today signed a partnership agreement with the Griffith University’s Institute for Glycomics.
　　The pair will strengthen collaborative drug research and development between Australia and China, positioning themselves as leaders in drug discovery and consolidate their r...

20

2010-05

Institut Pasteur of Shanghai and Hualan Biological Engineering Inc. create joint vaccine research laboratory

Announce today the creation of a Joint Laboratory for Vaccine Research and Development. The Joint Laboratory is set up at Institut Pasteur of Shanghai and will focus on research for novel vaccines The Joint Laboratory is funded by both IPS and Hualan and receives support from the Chinese Academy ...Shanghai, 27 April 2010. Institut Pasteur of Shanghai (IPS), an Institute of the Chinese Academy of Sciences, and Hualan Biological Engineering Inc. announce today the creation of a Joint Laboratory for Vaccine Research and Development. The Joint Laboratory is set up at Institut Pasteur of Shangh...